Remimazolam for Bronchoscopy in High-Risk Patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are classified as ASA 3 or 4 (moderate to severe risk for surgery).
- You are scheduled for a painless bronchoscopy.
- You are at least 18 years old.
- You do not regularly use strong painkillers, anti-anxiety meds, or antidepressants.
- Your body mass index (BMI) is between 18.5 and 30.
- Your oxygen level is 92% or higher when breathing room air.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This trial tests if remimazolam, a sedative, can reduce low oxygen levels during a procedure to collect eggs from the ovaries. It may be a safer option for people having this fertility treatment.
This study tests whether a sedative medication called remimazolam helps patients on breathing machines (ventilators) in the ICU recover better and have fewer complications. You would receive this medication to keep you calm and comfortable while on the ventilator.
This trial tests a newer anesthesia drug (remimazolam) combined with alfentanil against a standard drug (propofol) combined with alfentanil for people having chest surgery. The goal is to see which approach works better and is safer.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.
Hear when a new Pulmonary Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.